
Healthcare / Pharmaceuticals · NSE
Founded in June 1998, Quest Laboratories Limited is a well-known pharmaceutical company that produces a wide range of medicines, including antibiotics, antimalarials, pain relievers, respiratory treatments, diabetes medications, and antidepressants. The company operates across 12 states and 2 union territories in India, including Uttar Pradesh, Maharashtra, Delhi, Karnataka, and more. Headquartered in Dhar, Madhya Pradesh, Quest Laboratories runs advanced manufacturing facilities that meet strict international quality standards like WHO GMP, GLP, and ISO certifications. With a skilled team of 83 professionals handling production, quality control, engineering, inventory, and administration, the company is dedicated to maintaining top-quality standards and delivering reliable medical solutions.
Price Band
₹93 – ₹97
Issue Size
₹43.16 Cr
Lot Size
1200 shares
GMP
+82.5%
Est. Listing
₹177
at current GMP
Subscribed
85.34x
overall
Open
15 May 2024
Close
17 May 2024
Allotment
21 May 2024
Refund
22 May 2024
Demat Credit
23 May 2024
Listing
23 May 2024
Last updated: 19 Oct 2026
Current Premium
Issue Price (Upper)
₹97
Band: ₹93 – ₹97
Estimated Listing Price
₹177
Upper price + GMP
Lot Size
1200 shares
Min investment ₹1,16,400
Estimated Profit / Lot
₹96,000
1200 × ₹80
Grey Market Premium trend
+₹80
▲ 0 today
Updated less than a minute ago
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 31 Oct 2026 | +₹80 | 82.5% | ₹177 |
| 30 Oct 2026 | +₹80 | 82.5% | ₹177 |
| 29 Oct 2026 | +₹72 | 74.2% | ₹169 |
GMP is unofficial market data. Not a guarantee of listing performance.
Quest Laboratories Limited is bringing an initial public offering (IPO) in the Healthcare / Pharmaceuticals sector with an aggregate issue size of ₹43.16 Crores. The shares are offered at a price band of ₹93 to ₹97 per equity share on NSE. Currently, market analysts recommend evaluating the company's financial valuation, price-to-earnings (P/E) multiple, and peer comparison prior to submitting bids.
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Following the close of bidding on 2024-05-17, the basis of allotment is scheduled to be finalized on 2024-05-21. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Bigshare Services Private Limited) or the BSE allotment checking window.
The latest grey market premium for Quest Laboratories Limited IPO is ₹80, which indicates an expected listing price of ₹177.
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.